Self-reported non-receipt of HIV test results: A silent barrier to HIV epidemic control in Mozambique
December 6, 2019
In a recent study of self-reported non-receipt of HIV test results in Mozambican adults, VIGH researchers and colleagues discovered an understudied problem in HIV testing and counseling services and suggested targeted and individualized communication approaches for specific demographic groups.
Pediatric HIV researcher Carlucci discusses work in Mozambique
March 27, 2019
Posted in
http://news.vumc.org/2019/03/21/pediatric-hiv-researcher-carlucci-discusses-work-in-mozambique/
When James Carlucci, MD, MPH, instructor of Pediatric Infectious Diseases, is in Nashville he treats children at Monroe Carell Jr. Children’s Hospital at Vanderbilt. When he’s on one of the several trips he takes each year to Mozambique, he’s trying to understand when and why HIV-exposed infants fall out of care — and how to change it.
Featured Publication: Attrition of HIV-exposed infants from early infant diagnosis services in low- and middle-income countries: a systematic review and meta-analysis
November 30, 2018
Posted in
Research led by Vanderbilt investigators found nearly 40% of HIV-exposed infants in low‐ and middle‐income countries (LMIC) were not in care at 18 months of age or had died. Despite the availability and progress of HIV prevention of mother-to-child transmission (PMTCT) programs which includes postpartum follow-up of HIV-positive mothers and their HIV-exposed infants, many infants do not remain engaged in early infant diagnosis (EID) services that are essential to optimal health outcomes.
World Malaria Day Perspective: James Carlucci M.D.
April 24, 2017
World Malaria Day 2017, observed on Tuesday, April 25, seeks to raise awareness and highlight the need to close the gap in access to malaria prevention tools. While the burden of disease continues to decline, efforts to improve access to interventions that prevent, diagnose and treat malaria are needed to reach the Sustainable Development Goals of malaria elimination by 2030, especially in sub-Saharan Africa where malaria is most prevalent.